An innovative approach to accelerating drug release from 3D printed tablets

Últimas do Fórum Fóruns An innovative approach to accelerating drug release from 3D printed tablets

  • Este tópico está vazio.
Visualizando 1 post (de 1 do total)
  • Autor
  • #316

    3D printing technique has been considered for patient-specific dosage forms due to its potential applications. Nevertheless, one of the drawbacks is that 3D printing in tablet manufacturing requires a big amount of polymer, which slows down drug release. In the opposite side, conventional immediate release dosage forms involve compressing the powder with a disintegrating agent that enables rapid disintegration and dissolution upon oral ingestion.

    In this study, we demonstrate for the first time the use of a novel design approach of caplets with perforated channels to accelerate drug release from 3D printed tablets. This strategy has been implemented using a caplet design with perforating channels of increasing width (0.2, 0.4, 0.6, 0.8 or 1.0 mm) and variable length, and alignment (parallel or at right angle to tablet long axis). Hydrochlorothiazide (BCS class IV drug) was chosen as the model drug as enhanced dissolution rate is vital to guarantee oral bioavailability. The inclusion of channels exhibited an increase in the surface area/volume ratio, however, the release pattern was also influenced by the width and the length of the channel. A channel width was ≥ 0.6 mm deemed critical to meet the USP criteria of immediate release products. Shorter multiple channels (8.6 mm) were more efficient at accelerating drug release than longer channels (18.2 mm) despite having comparable surface area/mass ratio. This behaviour may be linked to the reduced flow resistance within the channels and the faster fragmentation during dissolution of these tablets.

    In conclusion, the width and length of the channel should be carefully considered in addition to surface area/mass when optimizing drug release from 3D printed designs. The incorporation of short channels can be adopted in the designs of dosage forms, implants or stents to enhance the release rate of eluting drug from polymer-rich structures.

    More about it


Visualizando 1 post (de 1 do total)
  • Você deve fazer login para responder a este tópico.